A detailed history of Vanguard Group Inc transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,504,314 shares of MEDP stock, worth $1.03 Billion. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,504,314
Previous 2,556,443 2.04%
Holding current value
$1.03 Billion
Previous $784 Million 29.16%
% of portfolio
0.02%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$284.87 - $413.31 $14.8 Million - $21.5 Million
-52,129 Reduced 2.04%
2,504,314 $1.01 Billion
Q4 2023

Feb 14, 2024

BUY
$227.52 - $312.68 $32.4 Million - $44.6 Million
142,591 Added 5.91%
2,556,443 $784 Million
Q3 2023

Nov 14, 2023

SELL
$233.98 - $281.67 $11.3 Million - $13.6 Million
-48,331 Reduced 1.96%
2,413,852 $584 Million
Q2 2023

Aug 14, 2023

SELL
$187.26 - $240.17 $37.1 Million - $47.6 Million
-198,206 Reduced 7.45%
2,462,183 $591 Million
Q1 2023

May 15, 2023

SELL
$174.31 - $239.52 $6.23 Million - $8.56 Million
-35,757 Reduced 1.33%
2,660,389 $500 Million
Q4 2022

Feb 10, 2023

SELL
$153.06 - $226.57 $11.7 Million - $17.3 Million
-76,507 Reduced 2.76%
2,696,146 $573 Million
Q3 2022

Nov 14, 2022

SELL
$145.13 - $182.49 $32.6 Million - $41 Million
-224,399 Reduced 7.49%
2,772,653 $436 Million
Q2 2022

Aug 12, 2022

SELL
$130.2 - $168.03 $17.1 Million - $22 Million
-131,169 Reduced 4.19%
2,997,052 $449 Million
Q1 2022

May 13, 2022

SELL
$138.87 - $214.31 $5.69 Million - $8.79 Million
-40,998 Reduced 1.29%
3,128,221 $512 Million
Q4 2021

Feb 14, 2022

BUY
$182.74 - $227.9 $393,621 - $490,896
2,154 Added 0.07%
3,169,219 $690 Million
Q3 2021

Nov 12, 2021

SELL
$170.18 - $198.21 $10.3 Million - $12 Million
-60,738 Reduced 1.88%
3,167,065 $599 Million
Q2 2021

Aug 13, 2021

BUY
$158.62 - $194.3 $512 Million - $627 Million
3,227,803 New
3,227,803 $570 Million

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $12.8B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.